Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects.

Brisson D, St-Pierre J, Santuré M, Hudson TJ, Després JP, Vohl MC, Gaudet D.

Int J Obes (Lond). 2007 Aug;31(8):1325-33. Epub 2007 Mar 6.

PMID:
17342071
3.
4.
5.

Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.

Perron P, Brisson D, Santuré M, Blackburn P, Bergeron J, Vohl MC, Després JP, Gaudet D.

J Endocrinol Invest. 2007 Jul-Aug;30(7):551-7.

PMID:
17848837
6.

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men.

Couillard C, Vohl MC, Engert JC, Lemieux I, Houde A, Almeras N, Prud'homme D, Nadeau A, Despres JP, Bergeron J.

J Lipid Res. 2003 May;44(5):986-93. Epub 2003 Feb 16.

7.
8.

Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice.

Takahashi T, Hirano T, Okada K, Adachi M.

Metabolism. 2003 Oct;52(10):1354-9.

PMID:
14564689
9.

Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.

Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V.

Int J Obes (Lond). 2007 Jun;31(6):913-8. Epub 2007 Feb 13.

PMID:
17299379
10.

Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency.

Garenc C, Couillard C, Laflamme N, Cadelis F, Gagné C, Couture P, Julien P, Bergeron J.

Eur J Hum Genet. 2005 Oct;13(10):1159-65.

11.

Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people.

Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F.

Int J Obes Relat Metab Disord. 1995 Apr;19(4):270-4.

PMID:
7627251
12.
13.

Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.

Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY.

J Stroke Cerebrovasc Dis. 2007 Jul-Aug;16(4):160-6.

PMID:
17689412
14.

Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.

Huang MC, Wang TN, Liu YL, Pa TH, Tu HP, Huang YC, Chang WT, Ko YC.

Circ J. 2006 Aug;70(8):1030-6.

15.

Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.

Minnich A, Kessling A, Roy M, Giry C, DeLangavant G, Lavigne J, Lussier-Cacan S, Davignon J.

J Lipid Res. 1995 Jan;36(1):117-24.

16.

Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin.

Howard BV, Zech L, Davis M, Bennion LJ, Savage PJ, Nagulesparan M, Bilheimer D, Bennett PH, Grundy SM.

J Lipid Res. 1980 Nov;21(8):1032-41.

17.

The g.-469G>A polymorphism in the GPIHBP1 gene promoter is associated with hypertriglyceridemia and has an additive effect on the risk conferred by LPL defective alleles.

Guay SP, Gaudet D, Brisson D.

Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):358-65. doi: 10.1016/j.numecd.2011.08.005. Epub 2011 Oct 5.

PMID:
21978733
18.

Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.

Robitaille J, Brouillette C, Houde A, Lemieux S, Pérusse L, Tchernof A, Gaudet D, Vohl MC.

J Hum Genet. 2004;49(9):482-9. Epub 2004 Aug 10.

PMID:
15309680
19.
20.

Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.

Reiber I, Mezõ I, Kalina A, Pálos G, Romics L, Császár A.

J Nutr Biochem. 2003 Jul;14(7):394-400.

PMID:
12915220

Supplemental Content

Support Center